πŸ‡ΊπŸ‡Έ FDA
Patent

US 12264149

Indazole compounds as kinase inhibitors

granted A61PA61P35/00

Quick answer

US patent 12264149 (Indazole compounds as kinase inhibitors) held by TYRA BIOSCIENCES, INC. expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TYRA BIOSCIENCES, INC.
Grant date
Tue Apr 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P35/00